4//SEC Filing
MCNAY JOSEPH C 4
Accession 0000914190-19-000061
CIK 0000707511other
Filed
Feb 28, 7:00 PM ET
Accepted
Mar 1, 4:44 PM ET
Size
19.1 KB
Accession
0000914190-19-000061
Insider Transaction Report
Form 4
MCNAY JOSEPH C
Director
Transactions
- Purchase
Convertible Promissory Note (right to buy)
2019-02-27$12500.00/shExercise: $0.12From: 2019-02-27Exp: 2024-02-27→ Common Stock (104,167 underlying) - Purchase
Common Stock Warrant (right to buy)
2019-02-27+78,125→ 78,125 totalExercise: $0.18From: 2019-08-27Exp: 2024-02-27→ Common Stock (78,125 underlying)
Holdings
- 100,000
Stock Option (right to buy)
Exercise: $0.19Exp: 2022-02-11→ Common Stock (100,000 underlying) - 120,000
Stock Option (right to buy)
Exercise: $0.21Exp: 2021-03-25→ Common Stock (120,000 underlying) - 100,000
Stock Option (right to buy)
Exercise: $0.64Exp: 2023-03-16→ Common Stock (100,000 underlying) - 100,000
Stock Option (right to buy)
Exercise: $0.36Exp: 2022-06-30→ Common Stock (100,000 underlying) - 125,000
Stock Option (right to buy)
Exercise: $0.28Exp: 2027-09-01→ Common Stock (125,000 underlying) - 6,524,122
Common Stock
- 8,024
Stock Option (right to buy)
Exercise: $0.57Exp: 2019-04-10→ Common Stock (8,024 underlying) - 50,000
Stock Option (right to buy)
Exercise: $0.16Exp: 2019-04-03→ Common Stock (50,000 underlying) - 200,000
Stock Option (right to buy)
Exercise: $0.21Exp: 2028-07-17→ Common Stock (200,000 underlying)
Footnotes (4)
- [F1]100% vested.
- [F2]25,000 shares vest on each of 3/16/16, 3/16/17, 3/16/18 and 3/16/19.
- [F3]31,250 shares vest on each of 9/1/17, 9/1/18, 9/1/19 and 9/1/20.
- [F4]50,000 shares vest on each of 7/17/18, 7/17/19, 7/17/20 and 7/17/21.
Documents
Issuer
REGENERX BIOPHARMACEUTICALS INC
CIK 0000707511
Entity typeother
Related Parties
1- filerCIK 0001257674
Filing Metadata
- Form type
- 4
- Filed
- Feb 28, 7:00 PM ET
- Accepted
- Mar 1, 4:44 PM ET
- Size
- 19.1 KB